These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31399787)

  • 1. Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma.
    Wang Y; Cui L; Zhang J; Zhang L; Zhang J; Zhao X; Chen Y
    Abdom Radiol (NY); 2019 Oct; 44(10):3370-3376. PubMed ID: 31399787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography perfusion imaging of renal cell carcinoma: systematic comparison with histopathological angiogenic and prognostic markers.
    Reiner CS; Roessle M; Thiesler T; Eberli D; Klotz E; Frauenfelder T; Sulser T; Moch H; Alkadhi H
    Invest Radiol; 2013 Apr; 48(4):183-91. PubMed ID: 23328912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion CT in patients with metastatic renal cell carcinoma treated with interferon.
    Ng CS; Wang X; Faria SC; Lin E; Charnsangavej C; Tannir NM
    AJR Am J Roentgenol; 2010 Jan; 194(1):166-71. PubMed ID: 20028919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-based radiomic model predicts high grade of clear cell renal cell carcinoma.
    Ding J; Xing Z; Jiang Z; Chen J; Pan L; Qiu J; Xing W
    Eur J Radiol; 2018 Jun; 103():51-56. PubMed ID: 29803385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juxtatumoral perinephric fat analysis in clear cell renal cell carcinoma.
    Gill TS; Varghese BA; Hwang DH; Cen SY; Aron M; Aron M; Duddalwar VA
    Abdom Radiol (NY); 2019 Apr; 44(4):1470-1480. PubMed ID: 30506142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Architectural Patterns are a Relevant Morphologic Grading System for Clear Cell Renal Cell Carcinoma Prognosis Assessment: Comparisons With WHO/ISUP Grade and Integrated Staging Systems.
    Verine J; Colin D; Nheb M; Prapotnich D; Ploussard G; Cathelineau X; Desgrandchamps F; Mongiat-Artus P; Feugeas JP
    Am J Surg Pathol; 2018 Apr; 42(4):423-441. PubMed ID: 29356723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Noninvasive Fuhrman grading of clear cell renal cell carcinoma using computed tomography radiomic features and machine learning.
    Nazari M; Shiri I; Hajianfar G; Oveisi N; Abdollahi H; Deevband MR; Oveisi M; Zaidi H
    Radiol Med; 2020 Aug; 125(8):754-762. PubMed ID: 32193870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis of renal cell carcinoma: perfusion CT findings.
    Chen Y; Zhang J; Dai J; Feng X; Lu H; Zhou C
    Abdom Imaging; 2010 Oct; 35(5):622-8. PubMed ID: 19763683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High perirenal fat thickness predicts a poor progression-free survival in patients with localized clear cell renal cell carcinoma.
    Huang H; Chen S; Li W; Wu X; Xing J
    Urol Oncol; 2018 Apr; 36(4):157.e1-157.e6. PubMed ID: 29307598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT texture analysis: a potential tool for prediction of survival in patients with metastatic clear cell carcinoma treated with sunitinib.
    Haider MA; Vosough A; Khalvati F; Kiss A; Ganeshan B; Bjarnason GA
    Cancer Imaging; 2017 Jan; 17(1):4. PubMed ID: 28114978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between CT perfusion parameters and Fuhrman grade in pTlb renal cell carcinoma.
    Chen C; Kang Q; Wei Q; Xu B; Ye H; Wang T; Lu Y; Lu J
    Abdom Radiol (NY); 2017 May; 42(5):1464-1471. PubMed ID: 27999886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic renal cell carcinoma: preliminary results from the Danish Renal Cancer Group Study-1.
    Mains JR; Donskov F; Pedersen EM; Madsen HH; Rasmussen F
    Invest Radiol; 2014 Sep; 49(9):601-7. PubMed ID: 24691140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma: predicting RUNX3 methylation level and its consequences on survival with CT features.
    Cen D; Xu L; Zhang S; Chen Z; Huang Y; Li Z; Liang B
    Eur Radiol; 2019 Oct; 29(10):5415-5422. PubMed ID: 30877466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor Enhancement on Dynamic CT: A Predictive Factor for Recurrence After Nephrectomy in Localized T1 Clear Cell Renal Cell Carcinoma.
    Maehara J; Nishie A; Asayama Y; Ishigami K; Ushijima Y; Takayama Y; Okamoto D; Fujita N; Sugimoto M; Inokuchi J; Honda H
    Anticancer Res; 2018 Apr; 38(4):2377-2383. PubMed ID: 29599364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
    Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
    Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the recurrence risk of renal cell carcinoma after nephrectomy: potential role of CT-radiomics for adjuvant treatment decisions.
    Deniffel D; McAlpine K; Harder FN; Jain R; Lawson KA; Healy GM; Hui S; Zhang X; Salinas-Miranda E; van der Kwast T; Finelli A; Haider MA
    Eur Radiol; 2023 Aug; 33(8):5840-5850. PubMed ID: 37074425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery.
    Leibovich BC; Lohse CM; Cheville JC; Zaid HB; Boorjian SA; Frank I; Thompson RH; Parker WP
    Eur Urol; 2018 May; 73(5):772-780. PubMed ID: 29398265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent.
    Kaiser A; Davenport MS; Hafez KS; Alva A; Bailey JJ; Francis IR
    AJR Am J Roentgenol; 2018 May; 210(5):1088-1091. PubMed ID: 29489406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade.
    Choi SY; Sung DJ; Yang KS; Kim KA; Yeom SK; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB; Lee JH
    Abdom Radiol (NY); 2016 Jun; 41(6):1160-9. PubMed ID: 27040407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.